Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-26

Clinical Trial Update: Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the combination of olanzapine and carbamazepine for bipolar disorder with mania. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEGRETOL (CARBAMAZEPINE)
  • Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED